Doxium For Varicose Veins

Get Rid Varicose Veins Naturally

Varicose Veins Holistic Treatments

Get Instant Access

Adamis, A. P. & Berman, A. J. (2008). Immunological mechanisms in the pathogenesis of diabetic retinopathy. Semin Immunopathol, Vol. 30, No. 2, (April 2008), pp.(65-84), ISSN 1863-2297

Adank, C. & Koerner, F. (1985). Calcium dobesilate in diabetic retinopathy. A retrospective controlled study. Ophthalmologica, Vol. 190, No. 2, (February 1985), pp. (102-111), ISSN 0030-3755

Aiello, L.M.. (2003). Perspectives on diabetic retinopathy. American journal of ophthalmology,

Vol. 136, No. 1, (July 2003), pp. (122-135), ISSN 0002-9394 Agolini, G. & Cavallini, G. M. (1987). Long-term therapy of retinal vasculopathies with oral administration of high doses of O-(beta-hydroxyethyl)-rutoside. La Clinica terapeutica, Vol. 120, No. 2, (January 1987), pp. (101-110), ISSN 0009-9074 Ak, G., Buyukberber, S., Sevinc., A, Turk, H. M., Ates, M., Sari, R., Savli, H. & Cigli, A.

(2001). The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with Type 2 diabetes mellitus. Journal of diabetes and its complications, Vol. 15, No. 3, (May-June 2001), pp. (150-157), ISSN 1056-8727 Allain, H., Ramelet, A. A., Polard, E. & Bentue-Ferrer, D. (2004). Safety of calcium dobesilate in chronic venous disease, diabetic retinopathy and haemorrhoids. Drug Safety, Vol. 27, No. 9, (August 2004), pp. (649-660), ISSN 0114-5916 Almarsson, O., Bourghol Hickey, M., Peterson, M. L., Zaworotko, M. J., Moulton, B. &

Rodriguez-Hornedo, N. (2011). US 7927613 (19.04.2011) Anderson, D., Yu,T. W., Phillips, B. J. & Schmezer, P. (1994). The effect of various antioxidants and other modifying agents on oxygen-radical-generated DNA damage in human lymphocytes in the COMET assay. Mutation Research -Fundamental and Molecular Mechanisms of Mutagenesis, Vol. 307, No. 1, (May 1994), pp. (261-270), ISSN 1386-1964 Barbieri, D., Grassilli, E., Monti, D., Salvioli, S., Franceschini, M. G., Franchini, A., Bellesia, E., Salomoni, P., Negro, P., Capri, M., Troiano, L., Cossarizza, A. & Franceschi, C. (1994). D-ribose and 2-deoxy-D-ribose induce apoptosis in human quiescent peripheral blood mononuclear cells. Biochemical and Biophysical Research Communications, Vol. 201, No. 3, (June 1994), pp. (1109-1116), ISSN 1090-2104 Barras, J. & Graf, C. (1980) Hyperviscosity in diabetic retinopathy treated with Doxium (calcium dobesilate). Vasa, Vol. 9, No. 2, (April-June 1980), pp. (161-164), ISSN0301-1526

Barber, A. J., Antonetti, D.A. & Gardner, T. W. (2000). Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. Investigative Ophthalmology and Visual Science, Vol. 41, No. 11, (October 2000), pp. (3561-3568), ISSN 1552-5783

Barnes, A.J., Locke, P., Scudder, P.R., Dormandy, T. L., Dormandy, J. A. & Slack, J. (1977). Is hyperviscosity a treatable component of diabetic microcirculatory disease? Lancet, Vol. 2, No. 8042, (October 1977), pp. (789-791), ISSN: 0140-6736 Benakis, A., Glasson, B., Bouvier, C. A., Ritschard, J., Krahenbuhl, B., Jung, A. & Hachen, H.

J. (1974). Metabolism and pharmacokinetics of calcium dobesilate in humans. Therapie, Vol. 29, No. 2, (March-April 1974), pp. (211-219), ISSN 0040-5957 Benes, L. & Farsa, O. (2007). Medicinal Chemistry. An instruction manual for practical courses. University of Veterinary and Pharmaceutical Sciences, ISBN 978-80-7305003-0, Brno, Czech Republic Brunet, J., Farine, J. C., Garay, R. P. & Hannaert, P. (1998a). In vitro antioxidant properties of calcium dobesilate. Fundamental & clinical pharmacology, Vol. 12, No. 2, (February 1998), pp. (205-212), ISSN 0767-3981 Brunet, J., Farine, J. C., Garay, R. P. & Hannaert, P. (1998b). Angioprotective action of calcium dobesilate against reactive oxygen species-induced capillary permeability in the rat. European Journal of Pharmacology,Vol. 358, No. 3, (October 1998), pp. (213220), ISSN 0014-2999

Bussolino, F., Biffignandi, P. & Arese, P. (1986). Platelet-activating factor: a powerful lipid autacoid possibly involved in microangiopathy. Acta Haematologica,Vol. 75, No. 3, (March 1986), pp. (129-140), ISSN 0001-5792 Campochiaro, P. A. (2000). Retinal and choroidal neovascularization. Journal of Cellular

Physiology, Vol. 184, No. 3, (September 2000), pp. (301-310), ISSN 0021-9541 Campochiaro, P. A. & Hackett, S. F. (2003). Ocular neovascularization: a valuable model system. Oncogene. Vol. 22, No.429, (Septebmer 2003), pp. (6537-6548). ISSN . 09509232

Cao, W., Jiang, Y. & Chen, Y. (2009). Clinical significance of changes of ET-1/CGRP contents in patients with diabetic retinopathy. Guoji Yanke Zazhi,Vol. 9, No. 2, (February 2009), pp. (309-310), ISSN 1672-5123 Caproiu, R., Praisler-Stoica, M., Tanase, A. & Georgescu, D. (1988). Characterization of calcium 2,5-dihydroxybenzenesulfonate (calcium dobesilate) by thermal analysis. Revistade Chimie, Vol. 39, No. 6, (June 1988), pp. (528-530), ISSN 0034-7752 Carrasco, O. F. & Vidrio, H. (2007). Endothelium protectant and contractile effects of the antivaricose principle escin in rat aorta. Vascular pharmacology,Vol. 47, No. 1, (July 2007), pp. (68-73), ISSN 1537-1891 Chen, Y. & Xiao, Y. (2008). Detection of calcium dobesilate in calcium dobesilate capsules: a comparison of HPLC and UV spectrophotometry. Guangdong Yaoxueyuan Xuebao, Vol. 24, No. 5, (May 2008), pp. (480-483), ISSN 1006-8783 Chung, H. K., Choi, S. M., Ahn, B. O., Kwak, H. H., Kim, J. H. & Kim, W. B. (2005). Arzneimittelforschung, Vol. 55, No. 10, (November 2005), pp. (573-80), ISSN 00044172

Clausen, P., Jacobsen, P., Rossing, K., Jensen, J. S., Parving, H. H. & Feldt-Rasmussen, B.

(2000). Plasma concentrations of VCAM-1 and ICAM-1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy. Diabetic medicine : a journal of the British Diabetic Association, Vol. 17, No. 9, (September 2000), pp.(644-649), ISSN 0742-3071

Cuevas, P. & Arrazola, J. M. (2005). Treatment of basal cell carcinoma with dobesilate.

Journal of the American Academy of Dermatology, Vol. 53, No. 3, (September 2005), pp. (525-526), ISSN 1368-5031 Cuevas, P., Díaz-González, D., Sánchez, I., Lozano, R, M., Giménez-Gallego, G. & Dujovny, M. (2006). Dobesilate inhibits the activation of signal transducer and activator of transcription 3, and the expression of cyclin D1 and bcl-XL in glioma cells. Neurological Research, Vol.28, No. 2, (March 2006), pp. (127-130, ISSN 0161-6412 Cuevas, P., Sanchez, I., Lozano, R. M. & Gimenez-Gallego, G.. (2005). Dobesilate is an angiogenesis inhibitor. European Journal of Medical Research,.Vol. 10, No. 9, (September 2005), pp. (369-372), ISSN 0949-2321 Czech Pharmacopoeia 2002. (2002). Grada, ISBN 80-247-0464-1, Prague, Czech Republic Czech Pharmacopoeia 2009. (2009). Grada, ISBN 80-247-2994-7, Prague, Czech Republic Durante, W., Sen, A. K., Sunahara & F. A. (1988). Impairment of endothelium-dependent relaxation in aortae from spontaneously diabetic rats. British Journal of Pharmacology, Vol. 94, No. 2, (June 1988), pp. (463-468), ISSN 0007-1188 Einarsdottir, A. B. & Stefansson, E. (2009). Prevention of diabetic retinopathy. Lancet, Vol.

373, No. 9672, (April 2009), pp. (1316-1318), ISSN 0140-6736 Estéve-Soler, J. (1977). Verfahren zur Herstellung des Kalziumsalzes der 2,5-

dihydroxybenzolsulfonsäure. DD 125668 (11.5.1977) Estéve-Subirana, A. (1970): Therapeutically active derivatives of p-dihydroxybenzene. US 3509207 (28.4.1970)

European Pharmacopoeia 7.2. (2011). European Directorate for the Quality of Medicines &

Health Care, ISBN 978-92-871-6704-0, Strasbourg Cedex, France Farsa O., Sablatura M. (2008). An alternative synthesis of calcium dobesilate, a simple venous insufficiency drug, suitable for use in medicinal or organic Chemistry practical courses. Khimyia/Chemistry, Vol. 17, No. 4 (July-August 2008), pp. (281285), ISSN 0861-9255

García Benayas, E., García Díaz, B. & Pérez, G. (1997). Calcium dobesilate-induced agranulocytosis. Pharmacy world & science, Vol. 19, No. 5, (October 1997), pp. (251252), ISSN 0928-1231

Garay, R.P., Hannaert, P. & Chiavaroli, C. (2005). Calcium dobesilate in the treatment of diabetic retinopathy. Treatments in Endocrinology, Vol. 4, No. 4, (July-August 2005), pp. (221-232), ISSN 1175-6349 Goldman, D. (2005). Method of preparation of mixed phase co-crystals with active agents.

CA 2548281 (23.06.2005) Graber, R., Farine, J. C., Fumagalli, I., Tatti, V. & Losa, G.A. (1998). Calcium Dobesilate protects human peripheral blood mononuclear cells from oxidation and apoptosis. Apoptosis, Vol 3, No. 1, (1998), pp. (41-49), ISSN 1360-8185 Guangzhi, H., Long, C., Yong, G., Shijun, S. & Xiaolai, W. (2009). Selective electrochemical sensing of calcium dobesilate based on the nano-Pd/ CNTs modified pyrolytic graphite electrode. Talanta, Vol. 78, No.3, (March 2009), pp. (1211-1214), ISSN . 0039-9140

Haritoglou, C, Gerss, J., Sauerland, C., Kampik, A. & Ulbig, M. W. (2009). Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial. The Lancet, Vol. 373, No. 9672, (April 2009), pp. (1364 - 1371), ISSN 0140-6736

Heidrich, H., Gerke, E. & Nekarda, H. (1983). Thrombozytenaggregationshemmung unter Calciumdobesilat. Arzneimittel-Forschung/Drug Research,Vol. 33, No. 4, (April 1983), pp. (580-582), ISSN 0004-4172 Hoare, E., Barnes, A. & Normandy, J. (1976) Abnormal blood viscosity in diabetes mellitus and retinopathy. Biorheology , Vol. 13, No. 1, (January - February 1976), pp. (21-25), ISSN0006-355X

Hu, G. Ma, Y., Guo, Y. & Shao, S. (2009). Selective electrochemical sensing of calcium dobesilate based on an ordered mesoporous carbon-modified pyrolytic graphite electrode. Journal of Electroanalytical Chemistry,Vol. 633, No. 1, (August 2009), pp. (264-267), ISSN 1572-6657 Huang, Z. (2007). New formulations of 2,5-dihydroxybenzenesulfonic acid for improving microcirculation and protecting blood vessel. CN101081823 (05.12.2007) Hudomel, J., Nemeth, B., Palfalvy, M. & Farkas A. (1977). Effect of calcium dobesilate (Doxium) on blood hyperviscosity in cases of diabetic retinopathy. Ophthalmic Research, Vol. 9, No. 1, (January - February 1977), pp. (25-30), ISSN 0030-3747 Iriz, E., Vural C., Ereren, E., Poyraz, A., Erer, D., Oktar, L., Golgot, L., Halit, V., Soncul, H.

(2008). Effects of calcium dobesilate and diosmin-hesperidin on apoptosis of venous wall in primary varicose veins. Vasa, Vol. 37, No. 3, (August 2008), pp. (233240), ISSN 0301-1526

Joussen, A. M., Poulaki, V., Mitsiades, N., Kirchhof, B., Koizumi, K., Dohmen, S. & Adamis, A. P. (2002). Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. The FASEB Journal, Vol. 16, No. 3, (March 2002), pp. (438-440), ISSN 0892-6638 Kern, T. S. (2007). Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Experimental Diabetes Research, Vol. 2007, Article ID 95103, pp. (95-103), ISSN 1687-5214 Kim, M., Park, B.-Y., Moon, C.-H., Park, E.-K. & Kim, K. (2004). Composition containing horse chestnut extract for anti-angiogenic and matrix metalloproteinase inhibitory activity. EP 1438059 (July 21, 2004) Klaassen, I., Hughes, J. M., Vogels, I. M., Schalkwijk, C. G., Van Noorden, C. J. & Schlingemann, R. O. (2009). Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes. Experimental eye research, Vol. 89, No. 1, (June 2009), pp. (4-15), ISSN 0014-4835 Kracmar, J, Kracmarova, J., Kovarova, A. & Stejskal, Z. (1988). UV spectrophotometry in drug control. 37: New active substances containing benzene, pyridine and quinoline chromophores. Part 8: Impact of substitution and solvent. Pharmazie, Vol. 43, No. 3, (March 1988), pp.(173-176), ISSN 0031-7144 Kroncke, K.D., Fehsel, K. & Kolb-Bachofen, V. (1995). Inducible nitric oxide synthase and its product nitric oxide, a small molecule with complex biological activities. Biological Chemistry Hoppe-Seyler, Vol. 376, No. 6, (June 1995), pp. (327-343), ISSN 0177-3593 Kubes, P., Suzuki, M. & Granger, D.N. (1991). Nitric oxide: An endogenous modulator of leukocyte adhesion. Proceedings of the National Academy of Sciences of the United States of America, Vol. 88, No. 11, (June 1991), pp. (4651-4655), ISSN 0027-8424 Kulessa, W., Becker, E. W., Berg, P. A. (1992). Recurrence of agranulocytosis after taking calcium dobesilate. Deutsche medizinische Wochenschrift, Vol. 117, No. 10, (March 1992), pp. (372-374), ISSN 0012-0472

Lacombe, C., Lelievre, J. C., Bucherer, C. & Grimaldi, A. (1989). Activity of Daflon 500 mg on the hemorheological disorders in diabetes. International angiology : a journal of the International Union of Angiology, Vol. 8, Supl. 4, (October-December 1989), pp. (4848), ISSN 0392-9590

Larsen, H. W., Sander, E., Hoppe, R. (1977). The value of calcium dobesilate in the treatment of diabetic retinopathy. A controlled clinical trial. Diabetologia, Vol. 13, No. 2, (April 1977), pp. (105-109), ISSN 0012-186X Leal, E. C., Martins, J.,Voabil, P., Liberal, J., Chiavaroli, C., Bauer, J., Cunha-Vaz, J. & Ambrosio, A. F. (2010). Calcium dobesilate inhibits the alterations in tight junction proteins and leukocyte adhesion to retinal endothelial cells induced by diabetes. Diabetes, Vol. 59, No. 10, (October 2010), pp. (2637-2645), ISSN 0012-1797 Lozovskaia, E. L., Kaplunskii, G. D., Sapezhinskii, I. I. (1990). Superoxide dismutase activity and photosensitizing properties of 2,5-dihydroxybenzolsulfonate. Biofizika, Vol. 35, No. 6, (June 1990), pp. (912-916), ISSN 0006-3029 Lu, J. R. (2005). Synthesis and structural analysis of calcium dobesilate monohydrate.

Zhongguo Xiandai Yingyong Yaoxue, Vol. 22, No. 2, (February 2005), pp. (124-126), ISSN 1007-7693

Luo, X. X., Duan, J. G., Liao, P. Z., Wu, L., Yu, Y. G., Qiu, B., Wang, Y. L., Li, Y. M., Yin, Z. Q., Liu, X. L. & Yao, K. (2009). Effect of qiming granule on retinal blood circulation of diabetic retinopathy: a multicenter clinical trial. Chinese journal of integrative medicine, Vol. 15, No. 5, (October 2009), pp. (384-388), ISSN 1672-0415 McMillan, D. (1976). Plasma protein changes, blood viscosity and diabetic microangiopathy.

Diabetes, Vol. 25, No. Suppl. 2, (January 1976), pp. (25-33), ISSN 0012-1797 McVeigh, G. E., Brennan, G. M., Johnston, G. D., McDermott, B. J., McGrath, L. T., Henry, W.

R., Andrews, J. W. & Hayes, J. R. (1992). Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia, Vol. 35, No. 8, (August 1992), pp. (771-776), ISSN 0012-186X Michal, M. & Gotti, C. (1988). Effect of calcium dobesilate on platelet function. Thrombosis

Research, Vol. 51, No. 6, (September 1988), pp. (593-605), ISSN 0049-3848 Milne, G. W. A. (Ed.) (2002). Drugs: Synonyms & Properties. Ashgate Publ. Co., ISBN: 0-56608228-4, Brookfield, Vt., USA Miyamoto, K., Khosrof, S., Bursell, S. E., Rohan, R., Murata, T., Clermont, A. C., Aiello, L. P., Ogura. Y. & Adamis, A. P. (1999). Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proceedings of the National Academy of Sciences of the United States of America, Vol. 96, No. 19, (September 1999), pp. (10836-10841), ISSN 0027-8424 Moncada, S. & Higgs, A. (1993). The L-arginine-nitric oxide pathway. The New England Journal of Medicine, Vol. 329, No. 27, (December 1993), pp. (2002-2012), ISSN 00284793

Negritescu, S., Belu, D, Dragoi, R., Sisman, E., Cosmin, A., Candidatu, A. & Georgescu, D.

(1979). Analytical studies on 2,5-dihydroxybenzenesulfonic acid salts as antihemorrhagic drugs. Revistade Chimie, Vol. 30, No. 9, (September 1979), pp. (912915), ISSN: 0034-7752

Novacek, A., Sedlackova, V., Horacek, L. & Simek, P. (1987). A method of purification of 2,5-dihydroxybenzenedulfonic acid calcium salt. CS 8402981, (15.09.1987)

Nowak, M., Wielkoszynski, T., Marek, B., Kos-Kudla, B., Swigtochowska, E., Sieminska, L., Kajdaniuk, D., Glogowska-Szelag, J. & Nowak, K. (2008). Blood serum levels of vascular cell adhesion molecule (sVCAM-1), intercellular adhesion molecule (sICAM-1) and endothelial leucocyte adhesion molecule-1 (ELAM-1) in diabetic retinopathy. Clinical and experimental medicine, Vol. 8, No. 3, (September 2008), pp. (159-164), ISSN 1591-8890 Palacios, M., Knowles, R. G. & Palmer, R. M. J. (1989). Nitric oxides from L-arginine stimulates the soluble guanylate cyclase in adrenal glands. Biochemical and Biophysical Research Communications, Vol. 165, No. 2, (December 1989), pp. (802-810), ISSN 1090-2104

Palmer, R. M. J., Ashton D. S. & Moncada, S. (1988). Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature, Vol. 333, No. 6174, (June 1988), pp. (664-666), ISSN 0028-0836

Palmer, R. M. J., Rees, D. D., Ashton, D. S. & Moncada, S. (1988). L-Arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochemical and Biophysical Research Communications, Vol. 153, No. 3 , (June 1988), pp. (1251-1256), ISSN 1090-2104 Plessas, C. T., Karayannakos, P., Plessas, S. T., Costakis, A., Donta, I. & Skalkeas, G. (1986a).

Pharmacokinetics of calcium dobesilate in beagle dogs after a single administration. European journal of drug metabolism and pharmacokinetics, Vol. 11, No. 4, (April 1986), pp. (303-308), ISSN 0378-7966 Plessas, C. T., Karayannakos, P., Plessas, S. T., Costakis, A., Donta, I. & Skalkeas, G. (1986b).

Pharmacokinetics of calcium dobesilate in beagle dogs after repeated administration. European journal of drug metabolism and pharmacokinetics, Vol. 11, No. 4, (April 1986), pp. (309-312), ISSN 0378-7966 Radomski, M. W., Palmer, R. M. J. & Moncada, S. (1987a). Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. British Journal of Pharmacology, Vol. 92, No. 3, (November 1987), pp. (181-185), ISSN 0007-1188

Radomski, M. W., Palmer, R. M. J. & Moncada, S. (1987b). Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet, Vol. 2, No. 8567, (November 1987), pp. (1057-1059), ISSN 0140-6736 Rees, D. D., Palmer, R. M. J. & Moncada, S. (1989). Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proceedings of the National Academy of Sciences of the United States of America, Vol. 86, No. 9, (May 1989), pp. (3375-3381), ISSN 00278424

Ribeiro, M. L., Seres, A. I., Carneiro, A. M., Stur, M., Zourdani, A., Caillon, P. & Cunha-Vaz, J. G. (2006). Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study. Graefe's archive for clinical and experimental ophthalmology, Vol. 244, No. 12, (December 2006), pp. (1591-1600), ISSN 0721-832X

Rogers, R. D., Daly, D. T., Gurau, G., MacFarlane, D., Turanjanin, J., Dean, P. M., Scott, J., Bica, K. & Seddon, K. R. (2010). Dual functioning ionic liquids and salts thereof. World Patent Application WO 2010/078300 (08.07.2010) Rogers, R. D., Daly, D. T., Swatloski, R. P., Hough, W. L., Davis, J. H. Jr., Smiglak, M., Pernak, J. & Spear, S. K. (2007). Multi-functional ionic liquid compositions for overcoming polymorphism and imparting improved properties for active pharmaceutical, biological, nutritional, and energetic ingredients. US Patent Application 20070093462 (26.04.2007) Róna, K. & Ary, K. (2001). Determination of calcium dobesilate in human plasma using ion-pairing extraction and high-performance liquid chromatography. Journal of Chromatography B: Biomedical Sciences and Applications, Vol. 755, No. 1-2, (May 2001), pp. (245-251), ISSN 0378-4347 Rota, R., Chiavaroli, C., Garayc, R. P. & Hannaert, P. (2004). Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats. European Journal of Pharmacology, Vol. 495, No. 2-3, (July 2004), pp.(217- 224), ISSN 0014-2999

Rückauf H., Turek, F. & Dietrich, W. (1990). Verfahren zur Herrstellung von

Hydrogensulfitlösungen. DD 2S2S99 (26.9.1990) Ruiz, E., Lorente, R. & Tejerina, T. Effects of calcium dobesilate on the synthesis of endothelium-dependent relaxing factors in rabbit isolated aorta. British Journal of Pharmacology,Vol. 121, No. 4, (June 1997), p. (711-716), ISSN 0007-1188 Sablatura, M. (2006). Development and optimization of a novel exercise for practical courses in Medicinal Chemistry I. Master thesis. University of Veterinary and Pharmaceutical Sciences, Brno, Czech Republic Salama Benarroch, I., Nano, H., Pérez, H., Elizalde, F., Bisceglia, H. & Salama. A. (1977).

Assessment of calcium dobesilate in diabetic retinopathy. A double-blind clinical investigation. Ophthalmologica, Vol. 174, No. 1, (January 1977), pp. (47-51), ISSN 0030-3755

Schram, M. T., Stam, F., de Jongh, R. T., de Vries, G., van Dijk, R. A., Serné, E. H., Lampe, D., Nanayakkara, P. W., Tushuizen, M. E., Scheffer, P. G., Schalkwijk, C. G., Kamper A. M., Stehouwer, C. D . (2003). The effect of calcium dobesilate on vascular endothelial function, blood pressure, and markers of oxidation in obese male smokers: a placebo-controlled randomised clinical trial. Atherosclerosis, Vol. 170, No. 1, (September 2003), pp. (59-72), ISSN 0021-9150 Sci Finder (July 2011). Substance Detail 20123-80-2. In: Sci Finder, a Data Base of the American Chemical Society, 12. 07. 2011, Available from

https://scifinder.cas.org/ scifinder/view/scifinder/scifinderExplore.jsf Sevin, R., Cuendet, J. F. (1969a). The action of calcium dobesilate in diabetic retinopathy.

Bulletins et mémoires de la Société française d'ophtalmologie, Vol. 82, pp. (170-180), ISSN 0081-1092

Sevin, R., Cuendet, J. F. (1969b). Calcium dobesilate in diabetic retinopathy. Ophthalmologica,

Vol. 159, No. 1, (January-February 1969), pp. (126-135), ISSN 0030-3755 Seyda, A. (1883). Über Sulfonsäuren des Hydrochinons. Berichte der Deutschen Chemischen

Gesellschaft, Vol.16, No.1, (January-June 1883), pp. (687-694), ISSN 0009-2940 Sigma-Aldrich. (July 2011). SUPELCOSIL™ ABZ+Plus HPLC Column, In: Sigma-Aldrich online catalog, 12. 07. 2011, Available from

http://www.sigmaaldrich.com/ catalog/ProductDetail.do?lang=en&N4=59194C30 |SUPELCO&N5=SEARCH_CONCAT_PNO|BRAND_KEY&F=SPEC Skovborg, F., Nielsen, A.V., Schlichtkrull, J. & Ditzel, J. (1966). Blood-viscosity in diabetic patients. Lancet,Vol. 1, No. 7429, (January 1966), pp. (129-131), ISSN 0140-6736

Stamper, R. L., Smith, M. E., Aronson, S. B., Cavender, J. C., Cleasby, G. W., Fung, W. E. & Becker, B. (1978). The effect of calcium dobesilate on nonproliferative diabetic retinopathy: a controlled study. Ophthalmology, Vol. 85, No. 6, (June 1978), pp. (594606), ISSN 0161-6420

State Institute for Drug Control. (August 2011). SPC 98886. Summary of data concerning the preparation Danium ®., In: Medicinal products database, 02. 08. 2011, Available from http://www.sukl.eu/modules/medication/ search.php?data[search_for]=Danium &data[code]=&data[atc_group]=&data[material]=&data[path]=&data[reg]=&data[ radio]=none&data[rc]=&data[with_adv]=0&search=Search&data[listing]=20 Suschek, C., Kolb, H. & Kolb-Bachofen, V. (1997). Dobesilate enhances endothelial nitric oxide synthase-activity in macro- and microvascular endothelial cells. British Journal of Pharmacology. Vol. 122, No. 7, (December 1997), pp. (1502-1508), ISSN 0007-1188

Suschek, C., Rothe, H., Fehsel, K., Enczmann, J. & Kolb-Bachofen, V. (1993). Induction of a macrophage-like nitric oxide synthase in cultured rat aortic endothelial cells. Journal of Immunology, Vol. 151, (September 1993), pp. (3283-3291), ISSN 0022-1767 Szabo, M. E., Haines, D., Garay, E., Chiavaroli, C., Farine, J. C., Hannaert, P., Berta, A. & Garay, R. P. (2001). Antioxidant properties of calcium dobesilate in ischemic / reperfused diabetic rat retina. European Journal of Pharmacology, Vol. 428, No. 2, (October 2001), pp. (277-286), ISSN 0014-2999 Tawa, M., Almarsson, O. & Remenar, J. (2010) Pharmaceutical propylene glycol solvate compositions. US 7790905 (07.09.2010) Velpandian, T. (2006). Pharmacetical compositions of calcium dobesilate. IN 1327/DEL/2006 (01.06.2006)

Vinazzer, H. & Hachen, H. J. (1987). Influence of calcium dobesilate (Doxium) on blood viscosity and coagulation parameters in diabetic retinopathy. Vasa, Vol. 16, No. 2, (March - April 1987), pp. (190-192), ISSN 0301-1526 Vojnikovic, B. (1984). Hyperviscosity in whole blood, plasma, and aqueous humor decreased by doxium (calcium dobesilate) in diabetics with retinopathy and glaucoma: a double-blind controlled study. Ophthalmic Research, Vol. 16, No. 3, (May-June 1984), pp. (150-162), ISSN 0030-3747 Vojnikovic, B. (1991). Doxium (calcium dobesilate) reduces blood hyperviscosity and lowers elevated intraocular pressure in patients with diabetic retinopathy and glaucoma. Ophthalmic Research, Vol. 23, No. 1, (January-February 1991), pp. (12-20), ISSN 00303747

Wadworth, A. N. & Faulds, D. (1992). Hydroxyethylrutosides. A review of its pharmacology, and therapeutic efficacy in venous insufficiency and related disorders. Drugs, Vol. 44, No. 6, (June 1992), pp. (1013-1032), ISSN 0012-6667 Xu, H., Li, X., Zhang, J., Zhang, Z. & Liu, K. (2009). Analytical Letters, Vol. 42, No. 8, (May

2009), pp. (1094-1110), ISSN 0003-2719 Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y. & Kobayashi, M. (1988). A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature, Vol. 332, No. 6163, (March 1988), pp. (411-415), ISSN 0028-0836 Yang, E., Shim, J.S., Woo, H.-J., Kim, K.-W. & Kwon, H.J. (2007). Aminopeptidase N/CD13 induces angiogenesis through interaction with a pro-angiogenic protein, galectin-3.

Biochemical and Biophysical Research Communications, Vol. 363, No. 2, (November 2007), pp. (336-341), ISSN 1090-2104 Yang, Y., Ma G. & Long, H. (2010). Process for preparation of calcium dobesilate hydrate.

CN101880248 (10.11.2010) Yao, C. (2010). Process for preparation of calcium dobesilate nanopowder. CN 101898980 (1.12.2010)

Zhang, Y., Du, F. Y. & Wei, L. L. (2011). Electrochemical behavior of calcium dobesilate at a gold nanoparticles modified glassy carbon electrode and its determination. Fenxi Shiyanshi,Vol. 30, No. 3, (March 2011), pp. (50-53), ISSN 1000-0720 Zhang, Y. & Zhang, Z. F. (2009). Lihua Jianyan, Huaxue Fence, Vol. 45, No. 11, (June 2009), pp. (1296-1301), ISSN 1001-4020 Zhang, Z. & Xu, Z. (1999). Comparison of two titration methods of calcium 2,5-dihydroxybenzenesulfonate. Huagong Shikan, Vol. 13, No. 11, (November 1999), pp. (36-38), ISSN 1002-154X Zheng, J., Zhang, Y. & Yang, P. (2007). An ionic liquid-type carbon paste electrode for electrochemical investigation and determination of calcium dobesilate. Talanta. Vol. 73, No. 5, (April 2007), pp.(920-925), ISSN 0039-9140 Zhong, H. & Guo, L. (1997). The plasma levels of endothelin in diabetic retinopathy and their changes after treatment with doxium. Hunan Yike Daxue Xuebao - Bulletin of Hunan Medical University, Vol. 22, No. 1, (January 1997), pp. (56-58), ISSN 1000-5625 Zhu, F. & Chen, J. (2005). Determination of calcium dobesilate in drugs by HPLC. Baoji Wenli Xueyuan Xuebao, Ziran Kexueban, Vol. 25, No. 2, (February 2005), pp. (119121), ISSN 1007-1261

Zimmerman, G.A., Prescott, S.M. & McIntyre, T.M. (1992). Endothelial cell interactions with granulocytes: tethering and signalling molecules. Immunology Today,Vol. 13, No. 3, (March 1992), pp. (93-100), ISSN 0167-5699 Zivanovic, L., Zecevic, M., Markovic, S., Petrovic, S. & Ivanovic, I. (2005). Validation of liquid chromatographic method for analysis of lidocaine hydrochloride, dexamethasone acetate, calcium dobesilate, buthylhydroxyanisol and degradation product hydroquinone in suppositories and ointment. Journal of Chromatography A,Vol. 1088, No. 1-2, (September 2005), pp. (182-186), ISSN 0021-9673

Was this article helpful?

0 0
Relaxation Audio Sounds Autumn In The Forest

Relaxation Audio Sounds Autumn In The Forest

This is an audio all about guiding you to relaxation. This is a Relaxation Audio Sounds with sounds from Autumn In The Forest.

Get My Free MP3 Audio


Post a comment